Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

An anti-restenosis intraluminal stent material

An anti-restenosis and internal stent technology, applied in the field of medical materials, can solve the problems of vascular stenosis, poor clinical effect of endothelial inoculation, loss of EC function, etc.

Inactive Publication Date: 2019-10-18
HUNAN PROVINCIAL PEOPLES HOSPITAL +1
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Synthetic grafts have also been inoculated with endothelial cells, but the clinical outcome of endothelial inoculation is generally poor, most likely due to nonadhesive properties of the cells to the graft and / or loss of EC function due to ex vivo manipulation
CN105327399 provides a method for constructing artificial blood vessels, which introduces prokaryotic system expression vectors with hydrophilic and negatively charged polypeptide genes and cell adhesion-promoting polypeptide genes on the surface (Journal of DonghuaUniversity (English Edition), 2012, 29:26 -29; Bio-Medical Materials and Engineering, 2014, 24:2057–2064), which improves surface hydrophilicity and negative charge, increases endothelialization potential, and is beneficial to tissue healing and anticoagulation, but this technology is suitable for constructing artificial blood vessels, The materials used include polyester. Obviously, for the field of vascular stents that need to be degraded after vascular stenosis treatment, this material has natural non-biocompatibility and cannot provide the mechanical support properties required by vascular stents. At the same time, as mentioned above As mentioned above, if endothelial cell proliferation cannot maintain homeostasis, it will lead to the formation of vascular restenosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • An anti-restenosis intraluminal stent material
  • An anti-restenosis intraluminal stent material
  • An anti-restenosis intraluminal stent material

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Preparation of Vascular Stents with Microgrooves and Short Peptide Coating

[0055] Step 1: Obtain the base material of the prosthesis, a tubular material that can degrade pure iron;

[0056] Step 2: Utilize laser engraving technology to obtain rectangular microgrooves in the direction parallel to the matrix axis on the outer surface of the matrix material; there are 8 microgrooves, and the ratio of the total opening area of ​​the microgrooves to the total area of ​​the outer surface of the matrix is ​​1 / 12. The depth dimension of the bottom is 1 / 5 of the thickness of the substrate;

[0057]Step 3: Utilize conventional technology, obtain degradable fibrous composition, described composition comprises chitosan fiber, and the histidine chelated iron loaded on described chitosan by spraying, wherein histidine chelated iron The weight content of iron in the composition is 0.6%, the degradation cycle of the chitosan fiber is about 1 month, and the degradable fibrous compos...

Embodiment 2

[0062] Preparation of Vascular Stents with Microgrooves and Short Peptide Coating

[0063] The preparation process is the same as in Example 1, the difference being that the base material used in step 1 is degradable polycaprolactone; in step 2, the microgrooves are 3 annular grooves along the perimeter of the substrate, and the total opening area of ​​the microgrooves accounts for The ratio of the total area of ​​the outer surface of the matrix is ​​1 / 15, and the depth dimension of the bottom is 1 / 3 of the thickness of the matrix; the fibers described in step 3 are collagen fibers, and the degradation cycle is about 40 days, and the chelated iron is Cysteine ​​chelated iron, its weight content in the composition is 0.8%; the polymer in step 4 is polyvinyl alcohol, and its thickness is 1.5mm.

Embodiment 3

[0065] Preparation of Vascular Stents with Microgrooves and Short Peptide Coating

[0066] The preparation process is the same as in Example 1, the difference being that the matrix material used in step 1 is degradable poly(lactic acid-glycolic acid); in step 2, the microgrooves are 6 W-shaped grooves along the matrix axis, and the microgrooves The ratio of the total opening area to the total area of ​​the outer surface of the substrate is 1 / 10, and the depth dimension of the bottom is 1 / 4 of the thickness of the substrate; the weight content of the histidine chelated iron in the composition in step 3 is 1%; the coating thickness in step 4 is 1.8mm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
thicknessaaaaaaaaaa
thicknessaaaaaaaaaa
Login to View More

Abstract

The invention discloses an anti-restenosis intraluminal stent material. The anti-restenosis intraluminal stent material comprises a biocompatible endoprosthesis material, a micro slot, a composition capable of being degraded to release Fe<3+>, a degradable polymer coating and a short peptide layer, wherein the biocompatible endoprosthesis material comprises a basal body; a material of the basal body is degradable in a tissue body; the basal body is tubular, and has tubular inner and outer surfaces, and the inner surface forms a channel for allowing a tissue fluid, for example, blood, to pass through; the micro slot is positioned in the outer surface, the depth of the micro slot is smaller than the thickness of the tubular basal body, the micro slot can be a rectangular groove parallel to the axial direction of the basal body or an annular groove along the perimeter of the basal body or a W-shaped groove in the axial direction of the basal body; the composition capable of being degraded to release the Fe<3+> is loaded in a micro cavity, and can be degraded in the tissue to release the Fe<3+>; the degradable polymer coating coats on inner and outer surfaces of the basal body, and a degradation rate of the coating is higher than that of the basal body; the short peptide layer coats on the degradable polymer coating, and comprises a first short peptide and a second short peptide; the first short peptide and the second short peptide can be self-assembled to form hydrogel; and the hydrogel formed by self-assembling the short pepetide layer can be specially beneficial for climbing and covering of endothelial cells and regenerating of endodermis.

Description

Background technique [0001] The invention belongs to the field of medical materials, and in particular relates to an anti-restenosis intraluminal stent material, in particular, an anti-restenosis vascular stent material. [0002] In 1987, Sigwart et al. used intravascular metal stents for coronary arteries for the first time, and received unexpected results, which provided a good way for the treatment of vascular occlusion diseases. Coronary artery stent is a kind of intravascular stent made of metal stainless steel, which has good plasticity and geometric stability, and can be sent to the lesion site through a catheter in a closed state, and then expanded by balloon expansion. Play a role in supporting blood vessels. Coronary artery stent implantation effectively avoids acute atresia, elastic recoil, and abnormal vascular remodeling of the vessel wall after balloon dilation, making the initial lumen enlargement more obvious and the rate of restenosis (ISR) significantly redu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61L31/14A61L31/12A61L31/16
Inventor 谢琼李峰易文婷石佳明
Owner HUNAN PROVINCIAL PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products